These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 23591370)

  • 1. The GH/IGF-1 axis in ageing and longevity.
    Junnila RK; List EO; Berryman DE; Murrey JW; Kopchick JJ
    Nat Rev Endocrinol; 2013 Jun; 9(6):366-376. PubMed ID: 23591370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.
    Berryman DE; Christiansen JS; Johannsson G; Thorner MO; Kopchick JJ
    Growth Horm IGF Res; 2008 Dec; 18(6):455-71. PubMed ID: 18710818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion.
    Ruiz-Torres A; Soares de Melo Kirzner M
    Gerontology; 2002; 48(6):401-7. PubMed ID: 12393957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Longevity Hormone Klotho is a New Player in the Interacion of the Growth Hormone/Insulin-Like Growth Factor 1 Axis.
    Rubinek T; Wolf I; Modan-Moses D
    Pediatr Endocrinol Rev; 2016 Sep; 14(1):9-18. PubMed ID: 28508612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH and ageing: Pitfalls and new insights.
    Bartke A; Darcy J
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):113-125. PubMed ID: 28477727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity.
    Laron Z
    Novartis Found Symp; 2002; 242():125-37; discussion 137-42. PubMed ID: 11855684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity?
    Laron Z
    Mech Ageing Dev; 2005 Feb; 126(2):305-7. PubMed ID: 15621211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GH/IGF-I axis and longevity.
    Holzenberger M
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S23-7. PubMed ID: 15339240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction.
    Shimokawa I; Higami Y; Tsuchiya T; Otani H; Komatsu T; Chiba T; Yamaza H
    FASEB J; 2003 Jun; 17(9):1108-9. PubMed ID: 12692087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone, insulin-like growth factor-1 and the aging brain.
    Ashpole NM; Sanders JE; Hodges EL; Yan H; Sonntag WE
    Exp Gerontol; 2015 Aug; 68():76-81. PubMed ID: 25300732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The somatotropic axis and aging: Benefits of endocrine defects.
    Bartke A; List EO; Kopchick JJ
    Growth Horm IGF Res; 2016 Apr; 27():41-45. PubMed ID: 26925766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease.
    Obermayr RP; Mayerhofer L; Knechtelsdorfer M; Mersich N; Huber ER; Geyer G; Tragl KH
    Exp Gerontol; 2005 Mar; 40(3):157-63. PubMed ID: 15763392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ageing, growth hormone and physical performance.
    Lanfranco F; Gianotti L; Giordano R; Pellegrino M; Maccario M; Arvat E
    J Endocrinol Invest; 2003 Sep; 26(9):861-72. PubMed ID: 14964439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age.
    Duran-Ortiz S; List EO; Basu R; Kopchick JJ
    Pituitary; 2021 Jun; 24(3):438-456. PubMed ID: 33459974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.
    Bartke A; Sun LY; Longo V
    Physiol Rev; 2013 Apr; 93(2):571-98. PubMed ID: 23589828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH/IGF-I/insulin system in centenarians.
    Vitale G; Barbieri M; Kamenetskaya M; Paolisso G
    Mech Ageing Dev; 2017 Jul; 165(Pt B):107-114. PubMed ID: 27932301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment in human ageing: benefits and risks.
    Giordano R; Bonelli L; Marinazzo E; Ghigo E; Arvat E
    Hormones (Athens); 2008; 7(2):133-9. PubMed ID: 18477550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.
    Anisimov VN; Bartke A
    Crit Rev Oncol Hematol; 2013 Sep; 87(3):201-23. PubMed ID: 23434537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-I regulates the age-dependent signaling peptide humanin.
    Lee C; Wan J; Miyazaki B; Fang Y; Guevara-Aguirre J; Yen K; Longo V; Bartke A; Cohen P
    Aging Cell; 2014 Oct; 13(5):958-61. PubMed ID: 25040290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.